SciClone Pharmaceuticals (Holdings) Limited (HK:6600) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
SciClone Pharmaceuticals (Holdings) Limited has disclosed its Board of Directors, comprising executive, non-executive, and independent members, with ZHAO Hong as CEO and PAN Rongrong as CFO. The company has established three board committees—Audit, Remuneration, and Nomination—with specific directors allocated to each as members or chairpersons, ensuring governance and oversight.
For further insights into HK:6600 stock, check out TipRanks’ Stock Analysis page.